Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Grandview Medical Center
Birmingham, Alabama, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- St. Vincent'S Health System, Inc. D/b/a Ascension St. Vincent'S
Jacksonville, Florida, United States
- Hca Florida Mercy Hospital
Miami, Florida, United States
- St. Luke'S Boise Medical Center
Boise, Idaho, United States
- Maine Medical Center
Portland, Maine, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
- Corewell Health William Beaumont Hospital
Royal Oak, Michigan, United States
- the Valley Hospital
Paramus, New Jersey, United States
- North Shore University Hospital, Northwell Health
Manhasset, New York, United States
- Doylestown Hospital
Doylestown, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Trident Medical Center
Charleston, South Carolina, United States
- Orion Medical
Houston, Texas, United States
- Methodist Hospital-San Antonio
San Antonio, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2024
- Primary completion
- 16 Nov 2025
- Completion
- 16 Nov 2025
- Last update posted
- 15 May 2026
- Registered enrollment
- 198
- Registry id
- NCT06364215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.